II. Indications
- FDA approved indications in adults
- Rheumatoid Arthritis
- Osteoarthritis
- Analgesic in mild to moderate pain
III. Contraindications
- See Salicylate
IV. Mechanism
- See Salicylate
- Difluorophenyl derivate of salicylic acid
- Unlike other Salicylates, Diflunisal is not metabolized to salicylic acid
- Results in a longer Half-Life than for other Salicylates
- As with other Salicylates and NSAIDs, has antipyretic, Analgesic and anti-inflammatory properties
- Blocks cyclooxygenase (COX, esp. COX1)
- Inhibits conversion of Arachidonic Acid to Prostaglandin precursors
- Decreasing Prostaglanding levels results in decreased pain, inflammation and fever
V. Dosing
- Diflunisal 250 to 500 mg orally every 8 to 12 hours
- Maximum: 1500 mg/day
VI. Adverse Effects
- See Salicylate
VII. Safety
- See Salicylate
- Avoid in Lactation
VIII. Resources
Images: Related links to external sites (from Bing)
Related Studies
diflunisal (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
DIFLUNISAL 500 MG TABLET | Generic | $0.83 each |